Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 3,879 |
|
|||||
| News | - | ||||||
| Day High | 1.99 | Low High |
|||||
| Day Low | 1.92 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aditxt Inc | ADTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0181 | -0.93% | 1.92 | 09:01:18 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.99 | 1.92 | 1.99 | 1.9381 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 44 | 3,879 | US$ 1.94 | US$ 7,520 | - | 1.91 - 68.08 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:03:36 | 2 | US$ 1.935 | USD |
Aditxt Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.23M | 1.67M | - | 645k | -32.7M | -19.64 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aditxt News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/29/2024 | 15:33 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 5/28/2024 | 05:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/22/2024 | 15:24 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/20/2024 | 15:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/15/2024 | 05:50 | PR Newswire (US) | Evofem Biosciences Announces Financial Results for the First.. |
| 5/13/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/08/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/07/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/03/2024 | 13:14 | Business Wire | CORRECTING and REPLACING Aditxt Announces Pricing of $4.2.. |
| 5/03/2024 | 08:00 | Business Wire | Aditxt Announces Pricing of $4.2 Million Private Placement.. |
| 4/02/2024 | 07:30 | Business Wire | Aditxt Signs a Definitive Agreement to Acquire Appili.. |
| 3/27/2024 | 07:36 | PR Newswire (US) | Evofem Reports $18.2 million of Phexxi Net Product Sales in.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.95 | 2.01 | 1.91 | 1.97 | 22,197 | -0.03 | -1.54% |
| 1 Month | 2.10 | 2.2499 | 1.91 | 2.05 | 25,235 | -0.18 | -8.57% |
| 3 Months | 3.66 | 5.45 | 1.91 | 3.27 | 352,310 | -1.74 | -47.54% |
| 6 Months | 3.41 | 9.50 | 1.91 | 5.46 | 777,018 | -1.49 | -43.70% |
| 1 Year | 24.604 | 68.08 | 1.91 | 8.70 | 556,607 | -22.68 | -92.20% |
| 3 Years | 111.20 | 1,139.60 | 1.91 | 48.58 | 2,255,267 | -109.28 | -98.27% |
| 5 Years | 211.20 | 1,139.60 | 1.91 | 72.50 | 2,150,770 | -209.28 | -99.09% |
Aditxt Description
| Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. |
